WHO

May 27, 1998 Department of State cable: REVISED DRUG STRATEGY AT W.H.O.: ATMOSPHERICS OF THE DEBATE, AND RECOMMENDED PLAN OF ACTION

CONFIDENTIAL RELEASED IN FULL
CONFIDENTIAL PTQ1906

PAGE 01 GENEVA 03470 01 OF 09 271621Z ACTION 10-00

425261 271705Z /38 O 271615Z MAY 98

FM USMISSION GENEVA
TO SECSTATE WASHDC IMMEDIATE 6208 INFO IO COLLECTIVE AMEMBASSY LONDON
AMEMBASSY BRASILIA
AMEMBASSY BUENOS AIRES AMEMBASSY PRETORIA AMEMBASSY HARARE
AMEMBASSY LILONGWE AMEMBASSY LUSAKA
AMEMBASSY WINDHOEK AMEMBASSY BERN
AMEMBASSY CANBERRA
AMEMBASSY STOCKHOLM AMEMBASSY TOKYO AMEMBASSY OSLO
AMEMBASSY BRUSSELS AMEMBASSY BONN
AMEMBASSY OTTAWA AMEMBASSY CAIRO CDC ATLANTA

Anne Marie Worning appointed as new acting head of WHO's team on public health, innovation and intellectual property

On 4 June 2010, Dr. Margaret Chan (Director General, World Health Organization) announced Dr. Anne Marie Worning as 'acting Director, Public Health, Innovation and Intellectual Property (PHI)'. According to the WHO website,

Dr Anne Marie Worning, a Danish national, is the Executive Director of the Director-General's Office since April 2009.

Global Health Progress/IFPMA fete African health ministers in Geneva on public private partnerships

On 19 May 2010, Global Health Progress (GHP) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) hosted a luncheon at the Vieux Bois in Geneva on the margins of the 63rd World Health Assembly for a targeted audience of over 90 persons including Ministers of Health, Ambassadors and senior officials from the Africa.

SAVE THE DATE: 19 May 2010-Moving beyond the EWG: Charting a new path for WHO to promote innovation AND access to medicines

Moving beyond the EWG: Charting a new path for WHO to promote innovation AND access to medicines

Non-governmental organization perspectives on de-linkage, prizes and the R+D Treaty

Date: Wednesday, 19 May 2010
Location: Salle XXV, Palais des Nations
Time: 13:00 to 14:30

I+A: Innovation+Access

Launch of 2.3(c) Committee: Salle XXV (Palais des Nations): May 19, 13:00 to 14:30

On Wednesday, 19 May 2010, the launch of the 2.3(c) Committee will take place at Room XXV of the Palais de Nations from 13:00 to 14:30. Element 2.3(c) of the WHO Global Strategy on Public Health, Innovation and Intellectual Property states:

encourage further exploratory discussions on the utility of possible instruments or mechanisms for essential health and biomedical R&D, including inter alia, an essential health and biomedical R&D treaty

WHO report on method of work of the governing bodies

Friday, 22 January 2010

The 126th session of the Executive Board (EB) of the World Health Organization has deliberated over a Report by the WHO Secretariat entitled "Method of work of the governing bodies" (EB126/26) "has taken note of the report".

Here are some choice excerpts from the report.

Dec 9, 2009 Wikileaks documents related to the WHO EWG

On December 9, 2009, Wikileaks posted five sensitive documents related to the WHO Expert Working Group (EWG) on R&D Financing:

  • a non-public draft report of the WHO EWG
  • a non-public Comparative Analysis done by the EWG
  • the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) Overview of the EWG Comparative Analysis
  • an IFPMA summary slide on the EWG Draft Report
  • Bolivian statement to EB 126 (Jan 2010) on public health, innovation and intellectual property

    This is the statement that the Government of Bolivia delivered on January 19, 2010 at the 126th session of the WHO Executive Board public health, innovation and intellectual property including their views on the EWG process and the Executive Summary of the WHO Expert Working Group on R&D Financing.

    The heart of Bolivia's intervention is encapsulated in the penultimate paragraph of their intervention.

    Syndicate content